Fear of cancer recurrence is not only normal, it’s one of the most common and persistent psychological challenges faced by cancer survivors, with studies showing that 59% of survivors experience ongoing concerns about their cancer returning or progressing. For many people, this fear doesn’t diminish after treatment ends; it can become a pervasive, debilitating worry that affects daily functioning, relationships, and quality of life in ways that standard cancer support programs rarely address directly. Wellspring offers the Fear of Recurrence Therapy (FORT) program — a clinically developed, therapist-led group intervention created by Dr. Sophie Lebel and Dr. Christine Maheu — specifically designed to teach practical coping strategies, build tolerance for uncertainty, and help survivors re-examine life priorities and set meaningful goals. The program is evidence-based, grounded in a published randomized controlled trial, and offered in a small-group format that creates both accountability and connection.
The Fear of Recurrence Therapy (FORT) program is a structured, co-facilitated therapist-led group intervention consisting of 6 weekly sessions of 2 hours each, with content that builds progressively from week to week. Session one introduces new skills for dealing with fear of recurrence; session two provides information on symptoms of cancer recurrence and begins building tolerance for uncertainty; session three focuses on expanding your coping toolkit; session four goes deeper into the underlying fears at the root of recurrence anxiety; session five focuses on moving beyond those specific fears; and session six brings the program to a close with a review and integration of everything learned. Across the six weeks, participants learn to differentiate between worrisome and harmless symptoms, identify triggers and less helpful coping patterns, and develop new strategies including relaxation techniques, cognitive restructuring, guided imagery, and goal-setting. Participants are also encouraged to complete homework between sessions to reinforce and deepen what is covered in class.
Fear of cancer recurrence has a distinct psychological profile that differs meaningfully from generalized anxiety — it is tied to specific triggers like follow-up appointments, physical symptoms, and anniversary dates, and it involves a particular kind of uncertainty that doesn’t resolve with reassurance alone. General support groups, while valuable, are not designed to address the cognitive and behavioral patterns that sustain recurrence fear at a clinical level. The FORT program was developed specifically to target these patterns, using evidence-based techniques including cognitive restructuring, uncertainty tolerance building, and values-based goal-setting that are tailored to the cancer recurrence experience. It is co-facilitated by trained therapists and delivered in a consistent small group of the same participants each week, creating the depth of trust and continuity that allows for the kind of honest, specific work this program requires.
Yes, and the evidence is specific to this program, not just to general psychological interventions. A randomized controlled trial of the Fear of Recurrence Therapy (FORT) program, published in in 2023 by the program’s developers Dr. Christine Maheu and Dr. Sophie Lebel, demonstrated the program’s effectiveness for cancer survivors experiencing fear of recurrence. An earlier feasibility study published in the Journal of Cancer Survivorship also found preliminary positive outcomes for women with cancer who participated in the program. The FORT program is therefore one of the few fear of recurrence interventions with its own dedicated clinical trial evidence, rather than being adapted from more general anxiety treatment research. For cancer survivors who have spent months or years managing this fear without effective tools, this level of evidence matters — it means the program was built for exactly this problem and has been tested on people in exactly this situation.
The pre-screening interview is a brief 15 to 20-minute phone call that takes place before you are confirmed as a participant in the FORT program. It exists to ensure that the program is the right fit for you at this point in your journey, and to give you the opportunity to ask questions and understand what the 6-week commitment involves before you begin. Because the program runs in a small, consistent group — with the same participants attending all six sessions — the pre-screening process helps ensure that the group dynamic will be supportive and productive for everyone involved. Content builds from week to week and participants complete homework between sessions, so the program works best for those who are ready for that level of engagement. Due to strong demand, submitting your pre-screening request as early as possible is the best way to secure your place in an upcoming series.
It is never too late — the FORT program is designed for cancer survivors at any point in their post-treatment journey, whether the fear of recurrence has been present since diagnosis or has intensified over time. In fact, for many survivors, the fear does not diminish as time passes and may even become more entrenched — which is precisely why a structured, evidence-based intervention like FORT exists. The program addresses not just the surface-level worry but the underlying fears, triggers, and coping patterns that sustain recurrence anxiety over the long term, which means it is as relevant for someone five years post-treatment as it is for someone newly finished. As one participant described it, the program provided “a wide range of practical tools” and meaningful support in navigating a new normal — and expressed deep gratitude for both the program’s content and its facilitators.